Monitoring Platelet Function During Continuous Hemodialysis
NCT ID: NCT01837758
Last Updated: 2017-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2012-12-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anticoagulation in Chronic Hemodialysis Patients Versus Hemodialyzer Fiber Patency, Bleedings and Quality of Life
NCT05365542
Impact of Dialysis Modality on Coagulation and Platelet Function
NCT04512131
Platelet Function in Hemodialysis Patient
NCT02792283
Optimisation of Anticoagulation in Patients on Nocturnal Hemodialysis
NCT05204810
Relationship Between Hemodynamic Change and Fluid Removed During Hemodialysis
NCT03901794
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dialysis
Platelet function will be documented during the first 48 hours of veno-venous hemofiltration using the Multiplate system.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Platelet Count \>100.000/nl
Exclusion Criteria
* Age \<18 years
* Renal replacement therapy within the 7 days prior to enrollment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Goethe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Saskia Wand
Dr. med Saskia Wand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johann Wolfgang Goethe-University
Frankfurt am Main, Hesse, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Daugirdas JT, Bernardo AA. Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia. Kidney Int. 2012 Jul;82(2):147-57. doi: 10.1038/ki.2012.130. Epub 2012 May 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CVVH-Multiplate
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.